AIMOVIG: payments to doctors
Payments that named AIMOVIG as the associated drug or biological, reported under the Sunshine Act for program years 2019–2025.
- Total reported
- $21.8M
- Providers
- 61,629
- Transactions
- 384,450
- Average per transaction
- $57
The per-transaction average — $57 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 61,629 providers the average total is $354, but that average hides a very steep distribution.
Companies reporting these payments
| Company | Total reported | Share |
|---|---|---|
| Amgen | $20,708,506 | 95.0% |
| Novartis | $1,066,298 | 4.9% |
| Novartis Pharma AG | $15,689 | 0.1% |